Safety and immunogenicity of a bivalent SARS-CoV-2 protein booster vaccine, SCTV01C, in adults previously vaccinated with mRNA vaccine: a randomized, double-blind, placebo-controlled phase 1/2 clinical trial

Autor: Hannawi, Suad, Saf Eldin, Linda, Abuquta, Alaa, Alamadi, Ahmad, Mahmoud, Sally A., Hassan, Aala, Liu, Dongfang, Yan, Lixin, Xie, Liangzhi
Zdroj: In eBioMedicine January 2023 87
Databáze: ScienceDirect